Effect of Herbal Medicine in the treatment of chronic bronchitis

Phase 3

Completed

• Conditions: Health Condition 1: J980- Diseases of bronchus, not elsewhere classified

• Registration Number: CTRI/2020/09/027746
• Lead Sponsor: Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-01-15
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 36

Inclusion Criteria

1.Symptoms of chronic bronchitis such as cough for at least 3 months from last 2 2.successive years sputum production shortness of breath wheezing which may be associated with symptoms such as fatigue sore throat nasal congestion headache or chest discomfort

3.Uncomplicated chronic bronchitis & those who willing to participate in the study for 8 weeks

Exclusion Criteria

1. Age of Patients below 18 years and above 60 Years.

2. Patients suffering from acute bronchitis having Peak expiratory flow rate (PEFR) <50% of the predicted value and having other pulmonary diseases like Emphysema, Cor-Pulmonale, Cyanosis, Pneumonia, Asthma, Cystic Fibrosis, Tuberculosis, Lung Cancer, Pleural Effusion, Mass Lesion, Pneumothorax, Bronchiolitis.

3. Patients with poorly controlled diabetes mellitus (HemoglobinA1c > 10%) and poorly controlled hypertension ( >160/100 mm of Hg), patients on prolonged ( >6 weeks) medication with corticosteroids, bronchodilators, mast cell stabilizers, antidepressants, anticholinergics or other drugs that may have an influence on the outcome of the study.

4. Patients suffering from major systemic illness necessitating long term drug treatment (rheumatoid arthritis, tuberculosis, psycho-neuro-endocrinal disorders, etc.) and patients with clinical evidence of heart failure

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PRIMARY OUTCOME:The trial drugs will help in relieving signs and symptoms of chronic bronchitis and thus will effective in the management of it.Timepoint: after 8 weeks

Secondary Outcome Measures

Name	Time	Method
ï?¶SECONDARY OUTCOME: The drug will improve the quality of life and thus will act as disease modifying after for Kaphaja Kasa. <br/ ><br> <br/ ><br>Timepoint: after 16 weeks